Health Behavior Associated with Anti-Mullerian Hormone (AMH) Relationship in Women with Polycystic Ovary (PCO) Syndrome

Abstract

Objectives: Polycystic ovary syndrome (PCOS) is becoming a common condition in the major adolescent population of Turkey. The objective of the present study was to examine the role of Anti-Mullerian hormone (AMH) levels in patients with different PCOS conditions in association with health behavior and the direct impact of AMH serum on PCOS. Lifestyle management strategies are strong determinants of regulating AMH. Methods: A total number of 2,260 voluntary were selected for the study, out of which 1630 participants in PCOS groups were divided into three subgroups on the basis of PCOS genotype i.e. Hiperandrojenizm (HA), PCOS, and Polycystic ovarian morphology (PCOM). A sample of 471 participants formed the PCOM group, 761 participants comprised the HA group, and 398 participants formed the PCOM-cum-HA group. The remaining 630 participants formed the control group. Results: The findings of the study indicate that higher AMH level is associated with negative health behaviors. Eating habits, weight management, smoking, and depression are found strong determinants of AMH which regulate the PCOS symptoms. It is also confirmed that women having PCOM and HA are more likely to develop PCOS conditions that cannot be cured easily. Conclusions: The adverse impact of health behavior is evident in the form of fertility issues resulting from PCOS. The conclusion is therefore drawn that the health behaviors control the AMH level which impacts the PCOS.